<DOC>
	<DOCNO>NCT02761330</DOCNO>
	<brief_summary>This study gear toward characterize recovery brain activity cognitive function follow treatment electroconvulsive therapy ketamine general anesthesia .</brief_summary>
	<brief_title>Cognitive Recovery After Electroconvulsive Therapy General Anesthesia</brief_title>
	<detailed_description>Seizures often associate loss consciousness , possibly effect sub-cortical arousal system , disruption cortical-subcortical interaction , ultimately depressed neocortical function . Furthermore , people often confuse post-ictal state even consciousness return seizure . Disrupted cognitive function postictal phase fully characterize present short long-term implication . Many experience acute disorder attention , consciousness , cognition , refer delirium . Memory deficit also common . The neurobiology phenomena incomplete challenge test , seizures typically sporadic vary intensity character . In contrast , set electroconvulsive therapy ( ECT ) provide opportunity study reconstitution consciousness cognition follow seizure elective predictable context . There standard agent use induce general anesthesia ECT . Ketamine receive great attention infusion treat depression potential benefit improve ECT efficacy expedite cognitive recovery . Further data need determine whether ketamine may improve recovery cognitive function relative etomidate , commonly use anesthetic general anesthesia ECT . The investigator evaluate cognition function electroencephalographic pattern accompany recovery ECT general anesthesia . Twenty patient refractory depression randomize interventional single-blinded randomize crossover trial . Each patient complete seven study visit . The first visit conduct dose-charge titration ECT treatment etomidate anesthesia . After session , patient randomize three session week two week ( six treatment total ) . Over first week patient randomize order three treatment arm : ( 1 ) etomidate general anesthesia ECT , ( 2 ) ketamine general anesthesia ECT , ( 3 ) ketamine alone . Patients blind treatment arm session . Baseline post-treatment measurement cognition ECT acquire six treatment session .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<criteria>Treatment resistant depression require outpatient ECT Planned right unilateral ECT stimulation English speaking Able provide write informed consent Known brain lesion neurological illness cause cognitive impairment Schizophrenia Schizoaffective disorder Blindness deafness motor impediment may impair performance cognitive test battery Inadequate ECT seizure duration etomidate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Anesthesia</keyword>
	<keyword>Electroconvulsive therapy</keyword>
	<keyword>Delirium</keyword>
	<keyword>Electroencephalography</keyword>
	<keyword>Seizures</keyword>
	<keyword>Depression</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Etomidate</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Confusion</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Neurobehavioral Manifestations</keyword>
	<keyword>Signs Symptoms</keyword>
	<keyword>Neurologic Manifestations</keyword>
	<keyword>Cognitive Disorders</keyword>
</DOC>